Truveta news For media inquiries, please email news@truveta.com Truveta Live Link: Enabling more complete real-world evidence and prospective research February 18, 2026 Clinical trials: Introducing real-time trial design, optimization, and evidence generation January 27, 2026 Why I’m joining Truveta January 26, 2026 Introducing Truveta Live Link January 13, 2026 Truveta recognized on national and Seattle LinkedIn Top Startup 2025 lists October 29, 2025 Transparency is the new standard: FDA’s view on regulatory-grade RWE October 3, 2025 Truveta adds new precision device data September 23, 2025 Celebrating 5 years of Saving Lives with Data September 22, 2025 1 2 … 10 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds February 10, 2026 Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services February 9, 2026 Truveta Research study published in Contraception advances understanding of women’s health and clinical guideline adoption February 2, 2026 Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation January 27, 2026 See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
Truveta Live Link: Enabling more complete real-world evidence and prospective research February 18, 2026
Clinical trials: Introducing real-time trial design, optimization, and evidence generation January 27, 2026
FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds February 10, 2026
Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services February 9, 2026
Truveta Research study published in Contraception advances understanding of women’s health and clinical guideline adoption February 2, 2026
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation January 27, 2026